Abstract
Mesoporous silica nanoparticles (MSNs) offer many advantageous properties for applications in the field of nanobiotechnology. Loading of small molecules into MSNs is straightforward and widely applied, but with the upswing of both research and commercial interest in biological drugs in recent years, also biomacromolecules have been loaded into MSNs for delivery purposes. MSNs possess many critical properties making them a promising and versatile carrier for biomacromolecular delivery. In this chapter, we review the effects of the various structural parameters of MSNs on the effective loading of biomacromolecular therapeutics, with focus on maintaining stability and drug delivery performance. We also emphasize recent studies involving the use of MSNs in the delivery of biomacromolecular drugs, especially for cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benezra, M., Penate-Medina, O., Zanzonico, P. B., Schaer, D., Ow, H., Burns, A., et al. (2011). Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. The Journal of Clinical Investigation, 121(7), 2768–2780.
Chen, F., Goel, S., Shi, S., Barnhart, T. E., Lan, X., & Cai, W. (2018). General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting. Nano Research, 11(9), 4890–4904.
Choi, Y. H., & Han, H. K. (2018). Nanomedicines: Current status and future perspectives in aspect of drug delivery and pharmacokinetics. Journal of Pharmaceutical Investigation, 48(1), 43–60.
Huang, M., Liu, L., Wang, S., Zhu, H., Wu, D., Yu, Z., et al. (2017). Dendritic mesoporous silica nanospheres synthesized by a novel dual-templating micelle system for the preparation of functional nanomaterials. Langmuir, 33(2), 519–526.
Zhan, Z., Zhang, X., Huang, J., Huang, Y., Huang, Z., Pan, X., et al. (2017). Improved gene transfer with functionalized hollow mesoporous silica nanoparticles of reduced cytotoxicity. Materials (Basel), 10(7), 731.
Xu, W., Ge, P., Niu, B., Zhang, X., Liu, J., & Xie, J. (2018). Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells. Journal of Colloid and Interface Science, 527, 141–150.
Zhang, B., Liu, Q., Liu, M., Shi, P., Zhu, L., Zhang, L., et al. (2019). Biodegradable hybrid mesoporous silica nanoparticles for gene/chemo-synergetic therapy of breast cancer. Journal of Biomaterials Applications, 33(10), 1382–1393.
Chen, C., Tang, W., Jiang, D., Yang, G., Wang, X., Zhou, L., et al. (2019). Hyaluronic acid conjugated polydopamine functionalized mesoporous silica nanoparticles for synergistic targeted chemo-photothermal therapy. Nanoscale, 11(22), 11012–11024.
Yu, L., Chen, Y., Lin, H., Gao, S., Chen, H., & Shi, J. (2018). Magnesium-engineered silica framework for pH-accelerated biodegradation and DNAzyme-triggered chemotherapy. Small, 14(35), e1800708.
Kao, K.-C., Lin, T.-S., & Mou, C.-Y. (2014). Enhanced activity and stability of lysozyme by immobilization in the matching nanochannels of mesoporous silica nanoparticles. The Journal of Physical Chemistry C, 118(13), 6734–6743.
Niu, D., Liu, Z., Li, Y., Luo, X., Zhang, J., Gong, J., et al. (2014). Monodispersed and ordered large-pore mesoporous silica nanospheres with tunable pore structure for magnetic functionalization and gene delivery. Advanced Materials, 26(29), 4947–4953.
Saikia, D., Deka, J. R., Wu, C. E., Yang, Y. C., & Kao, H. M. (2019). pH responsive selective protein adsorption by carboxylic acid functionalized large pore mesoporous silica nanoparticles SBA-1. Materials Science & Engineering. C, Materials for Biological Applications, 94, 344–356.
Siefker, J., Karande, P., & Coppens, M.-O. (2014). Packaging biological cargoes in mesoporous materials: Opportunities for drug delivery. Expert Opinion on Drug Delivery, 11(11), 1781–1793.
Kruk, M. (2012). Access to ultralarge-pore ordered mesoporous materials through selection of surfactant/swelling-agent micellar templates. Accounts of Chemical Research, 45(10), 1678–1687.
Bukara, K., Schueller, L., Rosier, J., Martens, M. A., Daems, T., Verheyden, L., et al. (2016). Ordered mesoporous silica to enhance the bioavailability of poorly water-soluble drugs: Proof of concept in man. European Journal of Pharmaceutics and Biopharmaceutics, 108, 220–225.
Xiong, L., Bi, J., Tang, Y., & Qiao, S. Z. (2016). Magnetic core-shell silica nanoparticles with large radial mesopores for siRNA delivery. Small, 12(34), 4735–4742.
Gu, J., Huang, K., Zhu, X., Li, Y., Wei, J., Zhao, W., et al. (2013). Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation. Journal of Colloid and Interface Science, 407, 236–242.
Wu, M., Meng, Q., Chen, Y., Zhang, L., Li, M., Cai, X., et al. (2016). Large pore-sized hollow mesoporous organosilica for redox-responsive gene delivery and synergistic cancer chemotherapy. Advanced Materials, 28(10), 1963–1969.
Meka, A. K., Abbaraju, P. L., Song, H., Xu, C., Zhang, J., Zhang, H., et al. (2016). A vesicle supra-assembly approach to synthesize amine-functionalized hollow dendritic mesoporous silica nanospheres for protein delivery. Small, 12(37), 5169–5177.
Rahmani, S., Budimir, J., Sejalon, M., Daurat, M., Aggad, D., Vives, E., et al. (2019). Large pore mesoporous silica and organosilica nanoparticles for pepstatin A delivery in breast cancer cells. Molecules, 24(2), 332.
Kwon, D., Cha, B. G., Cho, Y., Min, J., Park, E. B., Kang, S. J., et al. (2017). Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4. Nano Letters, 17(5), 2747–2756.
Cha, B. G., Jeong, J. H., & Kim, J. (2018). Extra-large pore mesoporous silica nanoparticles enabling co-delivery of high amounts of protein antigen and toll-like receptor 9 agonist for enhanced cancer vaccine efficacy. ACS Central Science, 4(4), 484–492.
Zhang, J., Li, X., Rosenholm, J. M., & Gu, H. C. (2011). Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles. Journal of Colloid and Interface Science, 361(1), 16–24.
Hong, Y., Yao, Y., Zhao, H., Sheng, Q., Ye, M., Yu, C., et al. (2018). Dendritic mesoporous silica nanoparticles with abundant Ti(4+) for phosphopeptide enrichment from cancer cells with 96% specificity. Analytical Chemistry, 90(12), 7617–7625.
Wang, Y., & Caruso, F. (2005). Mesoporous silica spheres as supports for enzyme immobilization and encapsulation. Chemistry of Materials, 17(5), 953–961.
Kalantari, M., Yu, M., Yang, Y., Strounina, E., Gu, Z., Huang, X., et al. (2017). Tailoring mesoporous-silica nanoparticles for robust immobilization of lipase and biocatalysis. Nano Research, 10(2), 605–617.
Yang, J., Tu, J., Lamers, G. E. M., Olsthoorn, R. C. L., & Kros, A. (2017). Membrane fusion mediated intracellular delivery of lipid bilayer coated mesoporous silica nanoparticles. Advanced Healthcare Materials, 6(20), 1700759.
Slowing, I. I., Trewyn, B. G., & Lin, V. S. (2007). Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. Journal of the American Chemical Society, 129(28), 8845–8849.
Hartono, S. B., Gu, W., Kleitz, F., Liu, J., He, L., Middelberg, A. P., et al. (2012). Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano, 6(3), 2104–2117.
Gao, F., Botella, P., Corma, A., Blesa, J., & Dong, L. (2009). Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. The Journal of Physical Chemistry B, 113(6), 1796–1804.
Xie, J., Yang, C., Liu, Q., Li, J., Liang, R., Shen, C., et al. (2017). Encapsulation of hydrophilic and hydrophobic peptides into hollow mesoporous silica nanoparticles for enhancement of antitumor immune response. Small, 13(40), 1701741.
Wu, M., Meng, Q., Chen, Y., Du, Y., Zhang, L., Li, Y., et al. (2015). Large-pore ultrasmall mesoporous organosilica nanoparticles: Micelle/precursor co-templating assembly and nuclear-targeted gene delivery. Advanced Materials, 27(2), 215–222.
Hartono, S. B., Yu, M., Gu, W., Yang, J., Strounina, E., Wang, X., et al. (2014). Synthesis of multi-functional large pore mesoporous silica nanoparticles as gene carriers. Nanotechnology, 25(5), 055701.
Zheng, Q., Lin, T., Wu, H., Guo, L., Ye, P., Hao, Y., et al. (2014). Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. International Journal of Pharmaceutics, 463(1), 22–26.
Liu, H. J., & Xu, P. (2019). Smart mesoporous silica nanoparticles for protein delivery. Nanomaterials (Basel), 9(4), 511.
Qiao, H., Jia, J., Shen, H., Zhao, S., Chen, E., Chen, W., et al. (2019). Capping silica nanoparticles with tryptophan-mediated cucurbit[8]uril complex for targeted intracellular drug delivery triggered by tumor-overexpressed IDO1 enzyme. Advanced Healthcare Materials, 8(13), e1900174.
Li, E., Yang, Y., Hao, G., Yi, X., Zhang, S., Pan, Y., et al. (2018). Multifunctional magnetic mesoporous silica nanoagents for in vivo enzyme-responsive drug delivery and MR imaging. Nano, 2(3), 233–242.
Portilho, F. L., Pinto, S. R., de Barros, A., Helal-Neto, E., Dos Santos, S. N., Bernardes, E. S., et al. (2018). In loco retention effect of magnetic core mesoporous silica nanoparticles doped with trastuzumab as intralesional nanodrug for breast cancer. Artificial Cells, Nanomedicine, and Biotechnology, 46(sup3), S725–SS33.
Siminzar, P., Omidi, Y., Golchin, A., Aghanejad, A., & Barar, J. (2019). Targeted delivery of doxorubicin by magnetic mesoporous silica nanoparticles armed with mucin-1 aptamer. Journal of Drug Targeting, 28(1), 92–101..
Sakhtianchi, R., Darvishi, B., Mirzaie, Z., Dorkoosh, F., Shanehsazzadeh, S., & Dinarvand, R. (2019). Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents. Pharmaceutical Development and Technology, 24(9), 1063–1075.
Li, X., Fan, H., Guo, T., Bai, H., Kwon, N., Kim, K. H., et al. (2019). Sequential protein-responsive nanophotosensitizer complex for enhancing tumor-specific therapy. ACS Nano, 13(6), 6702–6710.
Er, O., Colak, S. G., Ocakoglu, K., Ince, M., Bresoli-Obach, R., Mora, M., et al. (2018). Selective photokilling of human pancreatic cancer cells using cetuximab-targeted mesoporous silica nanoparticles for delivery of zinc phthalocyanine. Molecules, 23(11), 2749.
Fang, J., Wang, Q., Yang, G., Xiao, X., Li, L., & Yu, T. (2019). Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma. Colloids and surfaces B, Biointerfaces, 179, 250–259.
Paris, J. L., de la Torre, P., Cabanas, M. V., Manzano, M., Flores, A. I., & Vallet-Regi, M. (2019). Suicide-gene transfection of tumor-tropic placental stem cells employing ultrasound-responsive nanoparticles. Acta Biomaterialia, 83, 372–378.
Zahiri, M., Babaei, M., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2020). Hybrid nanoreservoirs based on dextran-capped dendritic mesoporous silica nanoparticles for CD133-targeted drug delivery. Journal of Cellular Physiology, 235(2), 1036–1050.
Shen, Y., Li, M., Liu, T., Liu, J., Xie, Y., Zhang, J., et al. (2019). A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. International Journal of Nanomedicine, 14, 4029–4044.
Liu, C. M., Chen, G. B., Chen, H. H., Zhang, J. B., Li, H. Z., Sheng, M. X., et al. (2019). Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Colloids and surfaces B, Biointerfaces, 175, 477–486.
Kuang, Y., Chen, H., Chen, Z., Wan, L., Liu, J., Xu, Z., et al. (2019). Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy. Colloids and surfaces B, Biointerfaces, 181, 461–469.
Yang, X., Trinh, H. M., Agrahari, V., Sheng, Y., Pal, D., & Mitra, A. K. (2016). Nanoparticle-based topical ophthalmic gel formulation for sustained release of hydrocortisone butyrate. AAPS PharmSciTech, 17(2), 294–306.
Shao, D., Li, M., Wang, Z., Zheng, X., Lao, Y. H., Chang, Z., et al. (2018). Bioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery. Advanced Materials, 30, e1801198.
Zhang, J., Shen, B., Chen, L., Chen, L., Meng, Y., & Feng, J. (2019). A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy. Colloids and Surfaces B, Biointerfaces, 175, 65–72.
Jimenez-Falcao, S., Joga, N., Garcia-Fernandez, A., Llopis Lorente, A., Torres, D., de Luis, B., et al. (2019). Janus nanocarrier powered by bi-enzymatic cascade system for smart delivery. Journal of Materials Chemistry B, 7(30), 4669–4676.
Agostini, A., Mondragon, L., Pascual, L., Aznar, E., Coll, C., Martinez-Manez, R., et al. (2012). Design of enzyme-mediated controlled release systems based on silica mesoporous supports capped with ester-glycol groups. Langmuir, 28(41), 14766–14776.
Deodhar, G. V., Adams, M. L., & Trewyn, B. G. (2017). Controlled release and intracellular protein delivery from mesoporous silica nanoparticles. Biotechnology Journal, 12(1), 1600408.
Xu, C., Lei, C., & Yu, C. (2019). Mesoporous silica nanoparticles for protein protection and delivery. Frontiers in Chemistry, 7, 290.
Tambe, P., Kumar, P., Paknikar, K. M., & Gajbhiye, V. (2018). Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells. International Journal of Nanomedicine, 13, 7669–7680.
Bhattacharyya, S., Wang, H., & Ducheyne, P. (2012). Polymer-coated mesoporous silica nanoparticles for the controlled release of macromolecules. Acta Biomaterialia, 8(9), 3429–3435.
Solberg, S. M., & Landry, C. C. (2006). Adsorption of DNA into mesoporous silica. The Journal of Physical Chemistry B, 110(31), 15261–15268.
Chang, J. H., Mou, K. Y., & Mou, C. Y. (2019). Sleeping beauty transposon-mediated asparaginase gene delivery by a nanoparticle platform. Scientific Reports, 9(1), 11457.
Nejabat, M., Mohammadi, M., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2018). Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma. Carbohydrate Polymers, 197, 157–166.
Pinese, C., Lin, J., Milbreta, U., Li, M., Wang, Y., Leong, K. W., et al. (2018). Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing. Acta Biomaterialia, 76, 164–177.
Wang, D., Xu, X., Zhang, K., Sun, B., Wang, L., Meng, L., et al. (2018). Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment. International Journal of Nanomedicine, 13, 187–198.
Pan, Q. S., Chen, T. T., Nie, C. P., Yi, J. T., Liu, C., Hu, Y. L., et al. (2018). In situ synthesis of ultrathin ZIF-8 film-coated MSNs for codelivering Bcl 2 siRNA and doxorubicin to enhance chemotherapeutic efficacy in drug-resistant cancer cells. ACS Applied Materials & Interfaces, 10(39), 33070–33077.
Li, Y., Duo, Y., Bi, J., Zeng, X., Mei, L., Bao, S., et al. (2018). Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy. International Journal of Nanomedicine, 13, 1241–1256.
Hu, Y., Wang, Z., Qiu, Y., Liu, Y., Ding, M., & Zhang, Y. (2019). Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma. Journal of Drug Targeting, 27(10), 1135–1143.
Yang, H., Liu, Y., Qiu, Y., Ding, M., & Zhang, Y. (2019). MiRNA-204-5p and oxaliplatin-loaded silica nanoparticles for enhanced tumor suppression effect in CD44-overexpressed colon adenocarcinoma. International Journal of Pharmaceutics, 566, 585–593.
Wang, F., Zhang, L., Bai, X., Cao, X., Jiao, X., Huang, Y., et al. (2018). Stimuli-responsive nanocarrier for co-delivery of MiR-31 and doxorubicin to suppress high MtEF4 cancer. ACS Applied Materials & Interfaces, 10(26), 22767–22775.
Joshi, V. B., Geary, S. M., & Salem, A. K. (2013). Biodegradable particles as vaccine delivery systems: Size matters. The AAPS Journal, 15(1), 85–94.
Slutter, B., & Jiskoot, W. (2016). Sizing the optimal dimensions of a vaccine delivery system: A particulate matter. Expert Opinion on Drug Delivery, 13(2), 167–170.
Mathaes, R., Winter, G., Siahaan, T. J., Besheer, A., & Engert, J. (2015). Influence of particle size, an elongated particle geometry, and adjuvants on dendritic cell activation. European Journal of Pharmaceutics and Biopharmaceutics, 94, 542–549.
Ding, D., & Zhu, Q. (2018). Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Materials Science & Engineering. C, Materials for Biological Applications, 92, 1041–1060.
Lee, S. H., Park, O. K., Kim, J., Shin, K., Pack, C. G., Kim, K., et al. (2019). Deep tumor penetration of drug-loaded nanoparticles by click reaction-assisted immune cell targeting strategy. Journal of the American Chemical Society, 141(35), 13829–13840.
Ding, B., Shao, S., Yu, C., Teng, B., Wang, M., Cheng, Z., et al. (2018). Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy. Advanced Materials, 30(52), e1802479.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Küçüktürkmen, B., Rosenholm, J.M. (2021). Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy. In: Fontana, F., Santos, H.A. (eds) Bio-Nanomedicine for Cancer Therapy. Advances in Experimental Medicine and Biology, vol 1295. Springer, Cham. https://doi.org/10.1007/978-3-030-58174-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-58174-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58173-2
Online ISBN: 978-3-030-58174-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)